Primary |
Asthma |
50.0% |
Prophylaxis |
19.2% |
Bronchitis |
7.7% |
Drug Use For Unknown Indication |
7.7% |
Bronchitis Chronic |
3.8% |
Emphysema |
3.8% |
Oral Candidiasis |
3.8% |
Product Used For Unknown Indication |
3.8% |
|
Cerebrovascular Accident |
16.7% |
Psychotic Disorder |
16.7% |
Tooth Disorder |
16.7% |
Anosmia |
8.3% |
Drug Exposure During Pregnancy |
8.3% |
Lymphadenopathy |
8.3% |
Psoriasis |
8.3% |
Systemic Candida |
8.3% |
Tremor |
8.3% |
|
Secondary |
Asthma |
37.5% |
Product Used For Unknown Indication |
22.5% |
Chronic Obstructive Pulmonary Disease |
15.0% |
Prophylaxis |
7.5% |
Diabetes Mellitus |
5.0% |
Hypertension |
5.0% |
Cerebrovascular Accident |
2.5% |
Coronary Artery Disease |
2.5% |
Migraine |
2.5% |
|
Bronchopulmonary Aspergillosis Allergic |
30.0% |
Cerebrovascular Accident |
30.0% |
Neurological Decompensation |
10.0% |
Paternal Drugs Affecting Foetus |
10.0% |
Vascular Dementia |
10.0% |
Weight Decreased |
10.0% |
|
Concomitant |
Product Used For Unknown Indication |
54.4% |
Drug Use For Unknown Indication |
9.6% |
Asthma |
7.6% |
Chronic Obstructive Pulmonary Disease |
3.7% |
Prophylaxis |
2.9% |
Hypertension |
2.8% |
Depression |
1.9% |
Rheumatoid Arthritis |
1.8% |
Atrial Fibrillation |
1.6% |
Pain |
1.6% |
Prostate Cancer |
1.5% |
Hiv Infection |
1.4% |
Non-small Cell Lung Cancer Metastatic |
1.4% |
Acute Graft Versus Host Disease |
1.3% |
Schizophrenia |
1.3% |
Cough |
1.2% |
Infection Prophylaxis |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Constipation |
0.9% |
Oedema Peripheral |
0.9% |
|
Wheezing |
10.4% |
Pneumonia |
6.6% |
Teeth Brittle |
6.6% |
Contusion |
5.7% |
Miosis |
5.7% |
Psychomotor Hyperactivity |
5.7% |
Transient Ischaemic Attack |
5.7% |
Vomiting |
5.7% |
White Blood Cell Count Increased |
5.7% |
Lower Respiratory Tract Infection |
4.7% |
Poor Quality Sleep |
4.7% |
Vision Blurred |
4.7% |
Withdrawal Syndrome |
4.7% |
Decreased Appetite |
3.8% |
Rash Generalised |
3.8% |
Renal Impairment |
3.8% |
Sepsis |
3.8% |
Anaphylactic Reaction |
2.8% |
Dyspnoea |
2.8% |
General Physical Health Deterioration |
2.8% |
|